These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 39337384

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Altered collagen turnover in factor VIII-deficient rats with hemophilic arthropathy identifies potential novel serological biomarkers in hemophilia.
    Manon-Jensen T, Karsdal MA, Nielsen LN, Kjelgaard-Hansen M, Vandahl B, Olsen EH, Enoksson M, Roepstorff K.
    J Thromb Haemost; 2016 Dec; 14(12):2419-2429. PubMed ID: 27681457
    [Abstract] [Full Text] [Related]

  • 3. The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy.
    Jansen NW, Roosendaal G, Lundin B, Heijnen L, Mauser-Bunschoten E, Bijlsma JW, Theobald M, Lafeber FP.
    Arthritis Rheum; 2009 Jan; 60(1):290-8. PubMed ID: 19116938
    [Abstract] [Full Text] [Related]

  • 4. Comparative Analysis of the Occurrence and Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Hemophilic Arthropathy and Osteoarthritis.
    Wojdasiewicz P, Poniatowski ŁA, Kotela A, Skoda M, Pyzlak M, Stangret A, Kotela I, Szukiewicz D.
    J Immunol Res; 2020 Jan; 2020():2932696. PubMed ID: 32884948
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hemophilic arthropathy of the elbow.
    Adams JE, Reding MT.
    Hand Clin; 2011 May; 27(2):151-63, v. PubMed ID: 21501786
    [Abstract] [Full Text] [Related]

  • 7. [Magnetic resonance Imaging in the diagnosis of hemophilic lesions of joints].
    Briukhanov AV, Fedorov VV, Mikhal'kov DF.
    Vestn Rentgenol Radiol; 1998 May; (5):25-9. PubMed ID: 9987940
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. What is the Effect of Bevacizumab on Cartilage and Synovium in a Rabbit Model of Hemophilic Arthropathy?
    Mert L, Bilgiç B, Şenol BK, Zülfikar OB, Durmaz H, Polat G.
    Clin Orthop Relat Res; 2023 Aug 01; 481(8):1634-1647. PubMed ID: 37036937
    [Abstract] [Full Text] [Related]

  • 10. Blood-induced joint disease: the pathophysiology of hemophilic arthropathy.
    Valentino LA.
    J Thromb Haemost; 2010 Sep 01; 8(9):1895-902. PubMed ID: 20586922
    [Abstract] [Full Text] [Related]

  • 11. The F8(-/-) rat as a model of hemophilic arthropathy.
    Sørensen KR, Roepstorff K, Wiinberg B, Hansen AK, Tranholm M, Nielsen LN, Kjelgaard-Hansen M.
    J Thromb Haemost; 2016 Jun 01; 14(6):1216-25. PubMed ID: 27060449
    [Abstract] [Full Text] [Related]

  • 12. Vascular remodeling underlies rebleeding in hemophilic arthropathy.
    Bhat V, Olmer M, Joshi S, Durden DL, Cramer TJ, Barnes RF, Ball ST, Hughes TH, Silva M, Luck JV, Moore RE, Mosnier LO, von Drygalski A.
    Am J Hematol; 2015 Nov 01; 90(11):1027-35. PubMed ID: 26257191
    [Abstract] [Full Text] [Related]

  • 13. Serological biomarkers in hemophilic arthropathy: Can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia?
    Rodriguez-Merchan EC.
    Blood Rev; 2020 May 01; 41():100642. PubMed ID: 31796337
    [Abstract] [Full Text] [Related]

  • 14. The Progression of Hemophilic Arthropathy: The Role of Biomarkers.
    Pasta G, Annunziata S, Polizzi A, Caliogna L, Jannelli E, Minen A, Mosconi M, Benazzo F, Di Minno MND.
    Int J Mol Sci; 2020 Oct 02; 21(19):. PubMed ID: 33023246
    [Abstract] [Full Text] [Related]

  • 15. Inflammatory diseases causing joint and bone destruction: rheumatoid arthritis and hemophilic arthropathy.
    Terashima A, Ono K, Omata Y, Tanaka S, Saito T.
    J Bone Miner Metab; 2024 Jul 02; 42(4):455-462. PubMed ID: 38856919
    [Abstract] [Full Text] [Related]

  • 16. Pathophysiology of hemophilic arthropathy and potential targets for therapy.
    Pulles AE, Mastbergen SC, Schutgens RE, Lafeber FP, van Vulpen LF.
    Pharmacol Res; 2017 Jan 02; 115():192-199. PubMed ID: 27890816
    [Abstract] [Full Text] [Related]

  • 17. RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology.
    Melchiorre D, Milia AF, Linari S, Romano E, Benelli G, Manetti M, Guiducci S, Ceccarelli C, Innocenti M, Carulli C, Civinini R, Morfini M, Matucci-Cerinic M, Ibba-Manneschi L.
    J Rheumatol; 2012 Aug 02; 39(8):1678-86. PubMed ID: 22753650
    [Abstract] [Full Text] [Related]

  • 18. Update on pathogenesis of the bleeding joint: an interplay between inflammatory and degenerative pathways.
    Van Meegeren M.
    Haemophilia; 2010 Jul 02; 16 Suppl 5():121-3. PubMed ID: 20590867
    [No Abstract] [Full Text] [Related]

  • 19. Hemophilic arthropathy: assessment with MR imaging.
    Yulish BS, Lieberman JM, Strandjord SE, Bryan PJ, Mulopulos GP, Modic MT.
    Radiology; 1987 Sep 02; 164(3):759-62. PubMed ID: 3615876
    [Abstract] [Full Text] [Related]

  • 20. Stromal cell-derived factor 1 alpha (SDF-1alfa) and cartilage oligomeric matrix protein (COMP): Two potential signature biomarkers of radiological detectable hemophilic arthropathy.
    Leuci A, Robert M, Josset L, Marano M, Connes P, Désage S, Meunier S, Lienhart A, Dargaud Y.
    Int J Rheum Dis; 2024 Feb 02; 27(2):e15061. PubMed ID: 38465833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.